Ignite Creation Date:
2024-05-06 @ 12:47 PM
Last Modification Date:
2024-10-26 @ 1:04 PM
Study NCT ID:
NCT03845582
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-30
First Post:
2019-02-15
Brief Title:
Phase 3 Study of ALK-001 in Geographic Atrophy
Sponsor:
Alkeus Pharmaceuticals Inc
Organization:
Alkeus Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Atrophy Geographic |
| Geographic Atrophy |
| Age Related Macular Degeneration |
| AMD |
Keywords: